SACHS BRUCE I 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed May 24, 2024
Insider Transaction Report
Form 4
SACHS BRUCE I
Director
Transactions
- Exercise/Conversion
Common Stock
2024-05-22$93.51/sh+7,073$661,396→ 47,073 total - Sale
Common Stock
2024-05-22$448.00/sh−7,073$3,168,704→ 40,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-05-22−7,073→ 0 totalExercise: $93.51Exp: 2026-05-31→ Common Stock (7,073 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1, which was entered into on 02/12/2024.
- [F2]Fully vested.